Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Research area

Epilepsy medication trials

If you want to know whether a study may be a fit, CNS Medication Trials can help you find out. Epilepsy research looks at investigational medications, devices, and monitoring tools for people who live with seizures.

Updated

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Epilepsy medication studies in numbers

epilepsy medication studies recruiting in the U.S.
36
states with a study site
32
studies that accept healthy volunteers
4

Source: ClinicalTrials.gov. Data processed .

Find epilepsy medication studies by state

These states have the most studies recruiting right now.

Epilepsy medication studies recruiting now

As of November 17, 2026, 36 epilepsy medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a medication, as each study is coded in the registry. This is what they have in common.

What they test

  • medications36
  • other approaches4
  • devices2
  • biologics such as vaccines or antibodies1

A study can test more than one.

Main purpose

  • treating a condition28
  • prevention3
  • basic science2
  • device feasibility1

Phase

  • Early Phase 13
  • Phase 13
  • Phase 1/24
  • Phase 28
  • Phase 2/32
  • Phase 311
  • Phase 45

Who runs them

  • industry18
  • university, hospital or other16
  • government2

Who they enroll

  • adults (18 to 64)28
  • older adults (65 and over)20
  • children (under 18)19

4 also accept healthy volunteers.

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 36 studies.

Recently updated epilepsy medication studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE

    • Phase 3
    • Ages 1 and older
    • All sexes
    Sponsor
    Jazz Pharmaceuticals
    Recruiting in
    Bethesda, MD · Honolulu, HI
    Registry record
    NCT07723976 · updated
  2. Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

    • Phase 4
    • Ages 18 and older
    • All sexes
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Boston, MA · Miami, FL · New York, NY · and 1 more U.S. location
    Registry record
    NCT04419272 · updated
  3. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Asheville, NC · Atlanta, GA · Bethesda, MD · and 14 more U.S. locations
    Registry record
    NCT07563881 · updated
  4. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Recruiting in
    Bentonville, AR · Chicago, IL · Colorado Springs, CO · and 9 more U.S. locations
    Registry record
    NCT07594119 · updated
  5. A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

    • Phase 2/3
    • Ages 10 and older
    • All sexes
    Sponsor
    Jazz Pharmaceuticals
    Recruiting in
    Honolulu, HI · Savannah, GA · Tampa, FL · and 1 more U.S. location
    Registry record
    NCT07723963 · updated
  6. Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

    • Phase 3
    • Ages 4 to 55
    • All sexes
    Sponsor
    SK Life Science, Inc.
    Recruiting in
    Baltimore, MD · Bethesda, MD · Durham, NC · and 4 more U.S. locations
    Registry record
    NCT05219617 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in the United States on ClinicalTrials.gov.

What epilepsy studies look at

When you start looking at an epilepsy study through CNS Medication Trials, you will soon see that no two ask the same things of you. Your part depends on the one question that particular study was set up to answer. If you live with seizures, research in this area may involve a medication, a device, or a monitoring tool. Each of those is investigational.

That word has a plain meaning here. The effect of the thing under test, and the risks that come with it, are not yet fully understood. Finding those answers is the reason a study is run at all.

Who may be able to take part

Before you can join an epilepsy study you find through CNS Medication Trials, the study team will check you against that study's own entry rules. They do this when you come in for screening. Judging your own eligibility beforehand is not something you are asked to do.

No single set of rules applies everywhere. A team may look at the medications you take now, your age, your health history, and the way the condition affects you. In some studies, people without the condition are enrolled too. Read our guide to screening and eligibility.

What taking part usually involves

  1. A first conversation

    Nothing else happens until a coordinator has given you a general outline of the epilepsy study and you have had your questions answered.

  2. Informed consent

    The study team then puts everything in writing for you, with the known risks set out alongside the rest. Whether you agree is yours to decide.

  3. Screening

    Next comes screening. The study team asks about your health and carries out tests, and the results tell them whether this CNS medication trial suits you. Some people are screened and do not go on to take part.

  4. Study visits

    After joining, you come in for visits on planned dates. These visits are how the study team follows your health while you are in the CNS medication trial. Leaving is your choice, and you can make it at any point.

Questions about epilepsy medication studies

Do I need a diagnosis to join a study about epilepsy?

The study team will tell you what applies to you, because it varies by study. Some require a confirmed diagnosis. Others assess you as part of screening.

Would I have to change the care I receive now?

The study doctor will go through your current care with you, because some CNS medication trials let it continue and others do not. Changing any part of your care is never something to do alone. Before you decide about a trial, you can also discuss it with your own doctor.

Is there a cost to take part?

You will generally find that study visits, study tests, and the study medication come at no cost to participants. Find out more about costs.

Ask about epilepsy medication studies

You will hear back from a coordinator after you send a few details. An enquiry about epilepsy studies at CNS Medication Trials is only an enquiry, and it places you under no obligation.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call